CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Mitchell L. Doucette - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Mitchell L. Doucette

OPENALEX: A5035581815↗ORCID: 0000-0002-5558-2218↗

Affiliations

Organizations

Baptist Hospital of Miamiauthorship · US Connecticut Children's Medical Centerauthorship · US Health Economics and Outcomes Research (United Kingdom)authorship · GB Health Outcomes Solutions (United States)authorship · US Johns Hopkins Universityauthorship · US

Public evidence

8 connected articles

Weed Out the Risk: Pharmacovigilance in Medical Cannabis Users2025 · medRxiv Identifying Predictors of Benzodiazepine Discontinuation in Medical Cannabis Patients with Post-traumatic Stress Disorder Using a Machine Learning Approach2025 · medRxiv Virtual Care and Medical Cannabis Access: A Geospatial Study of Telemedicine's Role in Reducing Socioeconomic Disparities2024 · medRxiv Impact of Medical Cannabis Treatment on Healthcare Utilization in PTSD Patients: A Retrospective Cohort Study2024 · medRxiv Measuring the Impact of Medical Cannabis Law Adoption on Employer-sponsored Health Insurance Costs: A Difference-in-Difference analysis, 2003-20222024 · medRxiv Medical Cannabis Use and Healthcare Utilization Among Patients with Chronic Pain: A Causal Inference Analysis Using TMLE.2025 · Europe PMC Disparities in Treatment Outcomes for Cannabis Use Disorder Among Adolescents.2025 · Europe PMC Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature.2024 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.